E Erdmann

2.5k total citations
115 papers, 1.7k citations indexed

About

E Erdmann is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, E Erdmann has authored 115 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in E Erdmann's work include Cardiac electrophysiology and arrhythmias (20 papers), Ion channel regulation and function (16 papers) and Cardiac Imaging and Diagnostics (9 papers). E Erdmann is often cited by papers focused on Cardiac electrophysiology and arrhythmias (20 papers), Ion channel regulation and function (16 papers) and Cardiac Imaging and Diagnostics (9 papers). E Erdmann collaborates with scholars based in Germany, United States and Austria. E Erdmann's co-authors include Michael Böhm, Wolfgang von Scheidt, Robert H. G. Schwinger, Peter Gierschik, Reinhard Kandolf, Christine M. Eng, Gerhard Hübner, Eckhardt G.J. Olsen, Thomas Fitzmaurice and Helen Christomanou and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American College of Cardiology.

In The Last Decade

E Erdmann

103 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Erdmann Germany 23 793 551 405 295 242 115 1.7k
Hozuka Akita Japan 27 915 1.2× 658 1.2× 754 1.9× 147 0.5× 182 0.8× 79 2.4k
Neville Bittar United States 18 718 0.9× 552 1.0× 274 0.7× 105 0.4× 296 1.2× 71 1.9k
Hidenori Urata Japan 29 1.8k 2.3× 518 0.9× 309 0.8× 112 0.4× 158 0.7× 107 2.8k
Xavier Maréchal France 25 581 0.7× 909 1.6× 264 0.7× 369 1.3× 70 0.3× 55 2.0k
Elena Osto Switzerland 25 728 0.9× 609 1.1× 298 0.7× 209 0.7× 195 0.8× 82 2.2k
Jo Satoh Japan 27 292 0.4× 480 0.9× 418 1.0× 378 1.3× 96 0.4× 66 2.5k
Attila Fehér United States 23 648 0.8× 395 0.7× 421 1.0× 158 0.5× 368 1.5× 74 1.8k
Riccardo Raddino Italy 21 627 0.8× 386 0.7× 173 0.4× 115 0.4× 96 0.4× 90 1.5k
Kazuhiro Sase Japan 18 792 1.0× 415 0.8× 621 1.5× 122 0.4× 72 0.3× 50 2.0k
Maike Knorr Germany 20 570 0.7× 766 1.4× 617 1.5× 171 0.6× 55 0.2× 50 2.1k

Countries citing papers authored by E Erdmann

Since Specialization
Citations

This map shows the geographic impact of E Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Erdmann more than expected).

Fields of papers citing papers by E Erdmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Erdmann. The network helps show where E Erdmann may publish in the future.

Co-authorship network of co-authors of E Erdmann

This figure shows the co-authorship network connecting the top 25 collaborators of E Erdmann. A scholar is included among the top collaborators of E Erdmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Erdmann. E Erdmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gassanov, Natig, Evren Caglayan, Amir M. Nia, E Erdmann, & Fikret Er. (2011). Hämodynamisches Monitoring auf der Intensivstation: Pulmonalarterienkatheter versus PiCCO. DMW - Deutsche Medizinische Wochenschrift. 136(8). 376–380. 9 indexed citations
2.
Schernthaner, G., Thomas Först, Dietrich C. Gulba, et al.. (2009). Herausforderung Diabetestherapie: Effekte der Glitazone jenseits der Blutzuckerkontrolle. DMW - Deutsche Medizinische Wochenschrift. 134(18). 949–954. 3 indexed citations
3.
Beuckelmann, D J & E Erdmann. (2008). Herzinsuffizienz bei dilatativer Kardiomyopathie: Eine Störung der zellulären Calcium-Homöostase*. DMW - Deutsche Medizinische Wochenschrift. 116(13). 504–508. 1 indexed citations
4.
Erdmann, E, et al.. (2007). Duale Thrombozytenaggregationshemmung bei koronarer Stentimplantation - Was ist gesichert?. DMW - Deutsche Medizinische Wochenschrift. 132(23). 1275–1280. 1 indexed citations
5.
Rottlaender, Dennis, G. Michels, E Erdmann, & Uta C. Hoppe. (2007). Therapie mit Glitazonen - ein kardiovaskuläres Risiko?. DMW - Deutsche Medizinische Wochenschrift. 132(49). 2629–2632. 5 indexed citations
6.
Flesch, Markus, Stephan Rosenkranz, E Erdmann, & Michael Böhm. (2001). Alcohol and the risk of myocardial infarction. Basic Research in Cardiology. 96(2). 128–135. 69 indexed citations
7.
Schneider, Christian, Eberhard Voth, Detlef Moka, et al.. (1999). Improvement of myocardial blood flow to ischemic regions by angiotensin- converting enzyme inhibition with quinaprilat IV. Journal of the American College of Cardiology. 34(4). 1005–1011. 22 indexed citations
9.
Baer, Frank M., Eberhard Voth, H. J. Deutsch, et al.. (1996). Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. Journal of the American College of Cardiology. 28(1). 60–69. 100 indexed citations
10.
Böhm, Michael, et al.. (1995). Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. The American Journal of Medicine. 98(2). 183–186. 49 indexed citations
11.
Kandolf, Reinhard, Karin Klingel, Heike Mertsching, et al.. (1991). Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. European Heart Journal. 12(suppl D). 49–55. 38 indexed citations
12.
Scheidt, Wolfgang von, Christine M. Eng, Thomas Fitzmaurice, et al.. (1991). An Atypical Variant of Fabry's Disease with Manifestations Confined to the Myocardium. New England Journal of Medicine. 324(6). 395–399. 297 indexed citations
13.
Schwinger, Robert H. G., Michael Böhm, & E Erdmann. (1990). The effect of xamoterol in failing human myocardium. European Heart Journal. 11(4). 323–327. 4 indexed citations
14.
Böhm, Michael, et al.. (1990). Different cardiodepressant potency of various calcium antagonists in human myocardium. The American Journal of Cardiology. 65(15). 1039–1041. 42 indexed citations
15.
Erdmann, E. (1989). The Value of Positive Inotropy in Acute and Chronic Heart Failure. Journal of Cardiovascular Pharmacology. 14(Supplement 3). S36–S41. 4 indexed citations
16.
Kreuzer, E., et al.. (1986). An Olympic Swinner. PubMed. 75 Suppl 2(12). 12–16. 1 indexed citations
17.
Erdmann, E, K.H. de Greef, J.C. Skou, & C. Achenbach. (1986). Cardiac glycosides 1785 - 1985 : biochemistry - pharmacology - clinical relevance. Springer eBooks. 12 indexed citations
18.
Erdmann, E. (1980). [Angina pectoris, pathological stress EKG and a normal coronary angiogram].. PubMed. 21(3). 165–8. 5 indexed citations
19.
Erdmann, E, W. Krawietz, & Walter Vogt. (1976). [Significance of serum digoxin concentration and its influencing factors].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 94(10). 567–73. 1 indexed citations
20.
Erdmann, E, et al.. (1976). The cardiac glycoside receptor: its properties and its correlation to nucleotide binding sites, phosphointermediate, and (Na++K+)-ATPase activity.. PubMed. 9. 329–35. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026